Iovance Biotherapeutics Inc
(NAS:IOVA)
$
10.13
-0.02 (-0.2%)
Market Cap: 3.07 Bil
Enterprise Value: 2.75 Bil
PE Ratio: 0
PB Ratio: 3.91
GF Score: 38/100 Iovance Biotherapeutics Inc at Stifel Virtual Healthcare Conference Transcript
Nov 18, 2020 / 01:00PM GMT
Release Date Price:
$36.5
(+0.91%)
Benjamin Jay Burnett
Stifel, Nicolaus & Company, Incorporated, Research Division - Associate
Good morning, everyone. Welcome to the first session of the day. I am happy to be here with Iovance with Howard Johnson, Chief Business Officer. We're going to do a kind of fireside chat. And of course, if you guys have questions, as always, put them through the dialogue, and I'll just get to them as they come.
Howard, thank you for being here.
Howard B. Johnson
Iovance Biotherapeutics, Inc. - SVP of Corporate Development, Alliance Management & Program Management
Thank you, Ben. Thanks for having me.
Benjamin Jay Burnett;Howard B. Johnson
Stifel, Nicolaus & Company, Incorporated, Research Division - Associate;Iovance Biotherapeutics, Inc. - SVP of Corporate Development, Alliance
Awesome. Maybe just to kind of kick it off. You guys have made a lot of progress over the last couple of months. Can you just give us maybe just a quick update, and then we'll get into Q&A.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot